Ente, Gleen .
HRN: 22-35-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/28/2022
01/03/2023
IVTT
500mg
Q8hrs
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes